We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




NMR Cold Probe for Biologic Research

By Biotechdaily staff writers
Posted on 13 May 2005
A novel new cryogenically cooled probe, the Salt Tolerant Cold Probe, yields more than a 20% higher sensitivity in salty samples that mimic physiologic conditions.

At higher salt concentrations, the sensitivity gain can be even greater, as much as 40%. More...
The probe, developed by Varian, Inc. (Palo Alto, CA, USA; www.varian.com), when used with the Varian nuclear magnetic resonance (NMR) system, achieves an even better performance.

The probe is initially designed for 500 and 600 MHz NMR spectrometers. The probe retains all the features and benefits of a conventional cold probe, including three to four times more sensitivity than a room temperature probe.

"This improved sensitivity should allow more pharmaceutical and academic laboratories to use the power of NMR for drug discovery and development. We are pleased to continue to expand the usage of this powerful and unique technology,” stated Jan Tschida, vice president and general manger of NMR systems, Varian.






Related Links:
Varian

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Pipette Calibration System
Artel PCS®
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.